Home › Markets › Health Care › IBO

Impact BioMedical Inc. (IBO)

IBO trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$3.98
-1.24% on the day
Market cap
$34.0M
Nano cap
Revenue · 2025
$32K
No prior year to compare
Net income · 2025
-$11.8M
-36993.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerIBO on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryNot reported by the screener
IPO year2024
SEC CIK0001834105
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials · 2025

LineValue
Revenue$32K
Net income-$11.8M
Operating income-$4.3M
Net margin-36993.8%
Operating margin-13381.3%
Revenue growthNo prior-year revenue to compare
Cash$3K
Total assets$17.4M
P/E (computed)Net income was not positive
P/S (computed)1062.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42024-09-17
Latest annual report10-K2026-03-11
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-10-09
Latest proxyDEF 14A2025-09-22

Source: SEC EDGAR submissions feed, 143 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
NNVCNanoViricides Inc.$1.32+3.13%$33.7M
CRVOCervoMed Inc.$2.27-9.56%$34.3M
JAGXJaguar Health Inc.$4.16-10.35%$32.5M
GRDXGridAI Technologies Corp.$4.55-2.36%$32.4M
CPHIChina Pharma Holdings Inc.$0.7514-13.53%$32.3M
BCTXBriaCell Therapeutics Corp. Common Shares$3.71-4.13%$32.3M
FLNAFilana Therapeutics Inc.$0.7434-3.39%$35.9M
IXHLIncannex Healthcare Inc.$2.91+0.34%$36.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier